High expression of CREPT promotes tumor growth and is correlated with poor prognosis in colorectal cancer
- 1 November 2016
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 480 (3) , 436-442
Abstract
No abstract availableKeywords
Funding Information
- National Natural Sciences Foundation of China (81630069, 81372225)
This publication has 15 references indexed in Scilit:
- Knockdown of COUP‐TFII inhibits cell proliferation and induces apoptosis through upregulating BRCA1 in renal cell carcinoma cellsInternational Journal of Cancer, 2016
- Non-canonical functions of cell cycle cyclins and cyclin-dependent kinasesNature Reviews Molecular Cell Biology, 2016
- Elevated expression of Thoc1 is associated with aggressive phenotype and poor prognosis in colorectal cancerBiochemical and Biophysical Research Communications, 2015
- Prognostic and Predictive Biomarkers in Colorectal Cancer. From the Preclinical Setting to Clinical PracticeCurrent Cancer Drug Targets, 2015
- Global cancer statistics, 2012CA: A Cancer Journal for Clinicians, 2015
- CREPT/RPRD1B, a Recently Identified Novel Protein Highly Expressed in Tumors, Enhances the β-Catenin·TCF4 Transcriptional Activity in Response to Wnt SignalingJournal of Biological Chemistry, 2014
- RPRD1B promotes tumor growth by accelerating the cell cycle in endometrial cancerOncology Reports, 2014
- Control of cell cycle transcription during G1 and S phasesNature Reviews Molecular Cell Biology, 2013
- CREPT Accelerates Tumorigenesis by Regulating the Transcription of Cell-Cycle-Related GenesCancer Cell, 2012
- Regulators of G1 cyclin–dependent kinases and cancersCancer and Metastasis Reviews, 2003